Figure 3.
Figure 3 illustrates the intravitreal drug concentration and free VEGF proportion in a patient treated with q4 (a), q8 (b), or q12 (c) 1.25 mg bevacizumab injections.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.